{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:02:11Z","timestamp":1794294131823,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jcrc.2024.154817","type":"journal-article","created":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T11:16:52Z","timestamp":1716808612000},"page":"154817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Prophylactic versus restrictive platelet transfusion strategy in patients with haematological malignancies in the ICU setting, a propensity-score analysis"],"prefix":"10.1016","volume":"83","author":[{"given":"Jean-Baptiste","family":"Berenger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colombe","family":"Saillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Sannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Servan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Faucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Manuel","family":"de Guibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Hospital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Bisbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Chow-Chine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamel","family":"Mokart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jcrc.2024.154817_bb0005","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1423-0410.2012.01627.x","article-title":"Platelet transfusions in haematology patients: are we using them appropriately?: platelet transfusions in haematology patients","volume":"103","author":"Estcourt","year":"2012","journal-title":"Vox Sang"},{"issue":"3","key":"10.1016\/j.jcrc.2024.154817_bb0010","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.hoc.2016.01.002","article-title":"Platelet transfusions in patients with Hypoproliferative thrombocytopenia","volume":"30","author":"Crighton","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.jcrc.2024.154817_bb0015","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/trf.12943","article-title":"Platelet transfusion: a systematic review of the clinical evidence: PLT TRANSFUSION SYSTEMATIC REVIEW","volume":"55","author":"Kumar","year":"2015","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.jcrc.2024.154817_bb0020","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M14-1589","article-title":"Platelet transfusion: a clinical practice guideline from the AABB","volume":"162","author":"Kaufman","year":"2015","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.jcrc.2024.154817_bb0025","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jcrc.2024.154817_bb0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"36","author":"Schiffer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.jcrc.2024.154817_bb0035","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.2022016558","article-title":"How I use platelet transfusions","volume":"140","author":"Stanworth","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jcrc.2024.154817_bb0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/MOH.0000000000000377","article-title":"Is there a standard-of-care for transfusion support of patients with haematological malignancies?","volume":"24","author":"Zhao","year":"2017","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154817_bb0045","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/vox.13387","article-title":"Systematic reviews on platelet transfusions: is there unnecessary duplication of effort? A scoping review","volume":"118","author":"Avau","year":"2023","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154817_bb0050","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/tmrv.2002.29403","article-title":"Do basic laboratory tests or clinical observations predict bleeding in thrombocytopenic oncology patients? A reevaluation of prophylatic, platelet transfusions","volume":"16","author":"Friedmann","year":"2002","journal-title":"Transfus Med Rev"},{"issue":"10","key":"10.1016\/j.jcrc.2024.154817_bb0055","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood-2017-01-757930","article-title":"Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial","volume":"130","author":"Uhl","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jcrc.2024.154817_bb0060","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.hoc.2007.06.010","article-title":"Platelet transfusion therapy","volume":"21","author":"Slichter","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"10.1016\/j.jcrc.2024.154817_bb0065","article-title":"A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Haematology Group, \u00e9diteur","volume":"2020","author":"Crighton","year":"2015","journal-title":"Cochrane Database Syst Rev [Internet]"},{"issue":"19","key":"10.1016\/j.jcrc.2024.154817_bb0070","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jcrc.2024.154817_bb0075","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/trf.16257","article-title":"Quality of evidence-based guidelines for platelet transfusion and use: a systematic review","volume":"61","author":"Al-Riyami","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.jcrc.2024.154817_bb0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.leukres.2018.02.015","article-title":"Early preemptive ICU admission for newly diagnosed high-risk acute myeloid leukemia patients","volume":"68","author":"Saillard","year":"2018","journal-title":"Leuk Res"},{"issue":"7","key":"10.1016\/j.jcrc.2024.154817_bb0085","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00134-019-05653-7","article-title":"Changes in critically ill cancer patients\u2019 short-term outcome over the last decades: results of systematic review with meta-analysis on individual data","volume":"45","author":"Darmon","year":"2019","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154817_bb0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13613-020-00764-7","article-title":"Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status","volume":"10","author":"Mokart","year":"2020","journal-title":"Ann Intensive Care"},{"issue":"9","key":"10.1016\/j.jcrc.2024.154817_bb0095","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00134-013-3022-9","article-title":"Thrombocytopenia in the critically ill: considering pathophysiology rather than looking for a magic threshold","volume":"39","author":"P\u00e8ne","year":"2013","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154817_bb0100","article-title":"Platelet transfusions in cancer patients with hypoproliferative thrombocytopenia in the intensive care unit","volume":"5","author":"Habr","year":"2015","journal-title":"Ann Intens Care [Internet]"},{"issue":"6","key":"10.1016\/j.jcrc.2024.154817_bb0105","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1097\/CCM.0000000000004887","article-title":"Impact of blood product transfusions on the risk of ICU-acquired infections in septic shock*","volume":"49","author":"P\u00e9ju","year":"2021","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jcrc.2024.154817_bb0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/trf.15596","article-title":"Post-transfusion platelet responses in critically ill cancer patients with hypoproliferative thrombocytopenia","volume":"60","author":"Baron","year":"2020","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.jcrc.2024.154817_bb0115","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcrc.2024.154817_bb0120","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1538-7836.2007.02313.x","article-title":"The scoring system of the scientific and standardisation committee on disseminated intravascular coagulation of the international society on thrombosis and haemostasis: a 5-year overview","volume":"5","author":"Toh","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jcrc.2024.154817_bb0125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.12688\/f1000research.20816.1","article-title":"Platelets treated with pathogen reduction technology: current status and future direction","volume":"9","author":"Lu","year":"2020","journal-title":"F1000Research"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154817_bb0130","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/2110-5820-2-42","article-title":"Management of thrombocytopenia in the ICU (pregnancy excluded)","volume":"2","author":"Van der Linden","year":"2012","journal-title":"Ann Intensive Care"},{"issue":"5","key":"10.1016\/j.jcrc.2024.154817_bb0135","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"11","key":"10.1016\/j.jcrc.2024.154817_bb0140","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00003246-198411000-00012","article-title":"A simplified acute physiology score for ICU patients","volume":"12","author":"Gall","year":"1984","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.jcrc.2024.154817_bb0145","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the working group on sepsis-related problems of the European Society of Intensive Care Medicine","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.1016\/j.jcrc.2024.154817_bb0150","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1537-2995.2007.01345.x","article-title":"Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 109 or 20 x 109 per L","volume":"47","author":"Nevo","year":"2007","journal-title":"Transfusion"},{"issue":"9850","key":"10.1016\/j.jcrc.2024.154817_bb0155","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jcrc.2024.154817_bb0160","doi-asserted-by":"crossref","first-page":"702","DOI":"10.5858\/2007-131-702-CROTAA","article-title":"Current risks of transfusion-transmitted agents: a review","volume":"131","author":"Stramer","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.jcrc.2024.154817_bb0165","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1213\/ANE.0000000000002794","article-title":"Prophylactic platelet transfusions for critically ill patients with thrombocytopenia: a single-institution propensity-matched cohort study","volume":"128","author":"Warner","year":"2019","journal-title":"Anesth Analges"},{"issue":"5","key":"10.1016\/j.jcrc.2024.154817_bb0170","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1378\/chest.06-3048","article-title":"Fresh-frozen plasma and platelet transfusions are associated with development of acute lung injury in critically ill medical patients","volume":"131","author":"Khan","year":"2007","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.jcrc.2024.154817_bb0175","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood.2020005985","article-title":"Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the sphingolipid rheostat","volume":"137","author":"McVey","year":"2021","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.jcrc.2024.154817_bb0180","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/j.1537-2995.2006.00979.x","article-title":"An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions","volume":"46","author":"Blumberg","year":"2006","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.jcrc.2024.154817_bb0185","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood-2002-03-0958","article-title":"Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors","volume":"101","author":"Silliman","year":"2003","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.jcrc.2024.154817_bb0190","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.thromres.2007.12.019","article-title":"Neutrophil CD40 enhances platelet-mediated inflammation","volume":"122","author":"Vanichakarn","year":"2008","journal-title":"Thromb Res"},{"issue":"4","key":"10.1016\/j.jcrc.2024.154817_bb0195","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00134-019-05884-8","article-title":"Transfusion strategies in non-bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine","volume":"46","author":"Vlaar","year":"2020","journal-title":"Intensive Care Med"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154817_bb0200","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/rth2.12004","article-title":"The association between platelet transfusions and bleeding in critically ill patients with thrombocytopenia","volume":"1","author":"Arnold","year":"2017","journal-title":"Res Pract Thromb Haemost"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154817_bb0205","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/aas.13699","article-title":"Thrombocytopenia in intensive care unit patients: a scoping review","volume":"65","author":"Jonsson","year":"2021","journal-title":"Acta Anaesthesiol Scand"},{"issue":"8","key":"10.1016\/j.jcrc.2024.154817_bb0210","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1182\/blood-2013-02-435693","article-title":"Platelet transfusions for critically ill patients with thrombocytopenia","volume":"123","author":"Lieberman","year":"2014","journal-title":"Blood"},{"issue":"26","key":"10.1016\/j.jcrc.2024.154817_bb0215","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1182\/blood-2016-09-693655","article-title":"How I evaluate and treat thrombocytopenia in the intensive care unit patient","volume":"128","author":"Greinacher","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154817_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/bjh.14482","article-title":"How do we approach thrombocytopenia in critically ill patients?","volume":"177","author":"Thachil","year":"2017","journal-title":"Br J Haematol"},{"issue":"24","key":"10.1016\/j.jcrc.2024.154817_bb0225","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1182\/blood-2015-11-680744","article-title":"Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients","volume":"127","author":"Claushuis","year":"2016","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.jcrc.2024.154817_bb0230","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/j.1538-7836.2004.01009.x","article-title":"Platelet function in sepsis","volume":"2","author":"Yaguchi","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.jcrc.2024.154817_bb0235","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/bjh.16291","article-title":"The association between haemorrhage and markers of endothelial insufficiency and inflammation in patients with hypoproliferative thrombocytopenia: a cohort study","volume":"189","author":"Ypma","year":"2020","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.jcrc.2024.154817_bb0240","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/bjh.13597","article-title":"Platelet refractoriness - practical approaches and ongoing dilemmas in patient management","volume":"171","author":"Stanworth","year":"2015","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.jcrc.2024.154817_bb0245","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/trf.12058","article-title":"The challenges of measuring bleeding outcomes in clinical trials of platelet transfusions: measuring bleeding in PLT transfusion trials","volume":"53","author":"Estcourt","year":"2013","journal-title":"Transfusion"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944124003046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944124003046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T15:30:39Z","timestamp":1730475039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944124003046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":49,"alternative-id":["S0883944124003046"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2024.154817","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prophylactic versus restrictive platelet transfusion strategy in patients with haematological malignancies in the ICU setting, a propensity-score analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2024.154817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154817"}}